Table 1. Cell cycle distribution of ZOL-treated cells.
Cell cycle distribution (% ± SE) | |||||
ZOL (Concentration) | Time | Sub-G1 | G0/G1 | S | G2/M |
(-) | 24 h | 1.00±0.08 | 54.83±0.46 | 19.34±0.17 | 25.18±0.37 |
(-) | 48 h | 2.66±0.10 | 78.68±0.27 | 7.68±0.27 | 10.82±0.12 |
(-) | 72 h | 6.83±0.15 | 82.23±0.29 | 2.87±0.16 | 8.68±0.07 |
10 µM | 24 h | 2.12±0.10 | 56.88±0.33 | 18.19±0.28 | 23.90±0.24 |
10 µM | 48 h | 4.75±0.13 | 80.28±0.13 | 6.13±0.19 | 9.38±0.14 |
10 µM | 72 h | 18.84±0.12 | 71.53±0.21 | 3.09±0.03 | 6.58±0.14 |
50 µM | 24 h | 2.01±0.16 | 64.58±0.11 | 13.97±0.18 | 19.78±0.11 |
50 µM | 48 h | 26.98±0.76 | 59.05±0.53 | 4.37±0.21 | 9.70±0.07 |
50 µM | 72 h | 79.14±0.32 | 15.65±0.13 | 4.73±0.06 | 1.22±0.11 |
MSTO-211H cells were treated with or without ZOL (at 10 or 50 µM) for 24–72 h. Cell cycle was analyzed with flow cytometry.